Donald Trump has rescinded an executive order from President Joe Biden that sought to lower the price of drugs.

On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...

Drugs used to treat cancer, diabetes and other chronic conditions are among 15 picked for negotiations that could result in ...

The Centers for Medicare & Medicaid Services announced 15 new drugs it wants to lower the cost for, including popular, but ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Trump’s early health orders signal plans to reverse Biden policies on drug prices and Medicaid. Experts predict more ...

Trump rescinded Executive Order 14087, "Lowering Prescription Drug Costs for Americans," which directed Medicare and Medicaid ...

Abe Sutton, a health policy aide in the first Trump administration, is likely to be named head of the Center for Medicare and ...

Trump Reportedly Picks Medicare Advantage Lobbyist for Top Health Budget Role. Don Dempsey would join Centers for Medicare and Medicaid Services nominee Mehmet Oz and other supporters of privatized ...

Don Dempsey, head of policy and research at lobbying group Better Medicare Alliance — funded by insurance companies including UnitedHealth Group and Humana — was the leading candidate to be Trump’s ...

The White House on Friday said Novo Nordisk’s weight-loss drugs Wegovy and Ozempic were among the 15 medications picked for a round of price negotiations with Medicare. The companies do not have ...

Health policy experts Chris Klomp, Stephanie Carlton and Abe Sutton appear favored for senior roles in the emerging Trump ...